Scn1a-KO 基因敲除小鼠

1. Depienne, C, Trouillard, O, Saint-Martin, C, Nabbout, R, LeGuern, E. 2008. Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. In Journal of medical genetics, 46, 183-91. doi:10.1136/jmg.2008.062323. https://pubmed.ncbi.nlm.nih.gov/18930999/

2. Tanenhaus, Annie, Stowe, Timothy, Young, Andrew, Belle, Archana, Tagliatela, Stephanie. . Cell-Selective Adeno-Associated Virus-Mediated SCN1A Gene Regulation Therapy Rescues Mortality and Seizure Phenotypes in a Dravet Syndrome Mouse Model and Is Well Tolerated in Nonhuman Primates. In Human gene therapy, 33, 579-597. doi:10.1089/hum.2022.037. https://pubmed.ncbi.nlm.nih.gov/35435735/

3. Ding, Jiangwei, Li, Xinxiao, Tian, Haiyan, Wang, Feng, Sun, Tao. 2021. SCN1A Mutation-Beyond Dravet Syndrome: A Systematic Review and Narrative Synthesis. In Frontiers in neurology, 12, 743726. doi:10.3389/fneur.2021.743726. https://pubmed.ncbi.nlm.nih.gov/35002916/

4. Han, Zhou, Chen, Chunling, Christiansen, Anne, Liau, Gene, Isom, Lori L. . Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome. In Science translational medicine, 12, . doi:10.1126/scitranslmed.aaz6100. https://pubmed.ncbi.nlm.nih.gov/32848094/

5. Valassina, Nicholas, Brusco, Simone, Salamone, Alessia, Broccoli, Vania, Colasante, Gaia. 2022. Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome. In Nature communications, 13, 161. doi:10.1038/s41467-021-27837-w. https://pubmed.ncbi.nlm.nih.gov/35013317/